4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-088041
Chief Financial Officer sold 23,347 shares at $6.13 ($143,117)
- Chief Financial Officer gave up 13,153 shares (to pay taxes)
- Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2015-12-30 | Shares withheld for taxes | −13,153 | $6.13 | $80,628 | 108,347 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2015-12-30 | Sale | −23,347 | $6.13 | $143,117 | 85,000 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-01-01 | Grant or award | +50,000 | 135,000 | D | ||
| Derivatives | |||||||
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-01-01 | Grant or award · Stock Option | +40,000 | 362,000 | D | ||
| Open-market sales · 23,347 sh · avg $6.13 · $143,117 | |||||||
Loading xslF345X03/doc4.xml…